Inhibition of the enhancer of zeste 2 PRC2 subunit (EZH2) was shown to reduce TGF‐β1‐induced human lung fibroblast‐to‐myofibroblast transformation and to attenuate bleomycin‐induced pulmonary fibrosis in mice (Xiao et al, 2016). The gene discussed is EZH2; the disease is pulmonary fibrosis.